Vana Kolovou, Genovefa Kolovou
Abstract
Pharmacogenetics explores heritable genetic polymorphisms that can effect responses to drug therapy. Many studies have focused on several genetic polymorphisms, which are involved in cholesterol metabolism, trying to define their contribution to a potential genotype-guided treatment against dyslipidemia.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Pharmacogenetics explores heritable genetic polymorphisms that can effect responses to drug therapy. Many studies have focused on several genetic polymorphisms, which are involved in cholesterol metabolism, trying to define their contribution to a potential genotype-guided treatment against dyslipidemia.
Key concepts: Pharmacogenetics, Dyslipidemia, Pharmacology, Medicine, Genotype, Bioinformatics, Open access publishing, Drug response